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Abstract
Background:  Vancomycin-resistant entrococci (VRE) are increasing in prevalence at many
institutions, and are often reported in dialysis patients. The aim of this cross-sectional prevalence
study was to determine the prevalence and risk factors of VRE colonization in chronic hemodialysis
patients in two hemodialysis centers in Shiraz, Iran.
Methods: Rectal swabs were obtained from all consenting patients and were streaked on the
surface of Cephalexin-aztreonam-arabinose agar (CAA) and incubated at 37°C in air for 24 h. The
vancomycin susceptibility of each isolate was confirmed by disk susceptibility testing. The MICs of
vancomycin and teicoplanin were confirmed by the E test. To identify risk factors, a questionnaire
was completed for all the studied patients and the data of VRE positive and negative groups were
compared using Man-Withney U test for continues data and the Fisher exact test for categorical
data.
Results: Of 146 patients investigated, 9 (6.2%) were positive for VRE. All VRE strains were
genotypically distinguishable. Risk factors for a VRE-positive culture were "antimicrobial receipt
within 2 months before culture" (P = 0.003) and "hospitalization during previous year" (P = 0.016).
Conclusion: VRE colonization is an under-recognized problem among chronic dialysis patients in
Iran. VRE colonization is associated with antibiotic consumption and hospitalization.
Background
The emergence and spread of glycopeptide resistance in
enterococci has become a substantial clinical and epide-
miological concern, and vancomycin-resistant entero-
cocci (VRE) are now an increasingly important problem in
hospitals worldwide [1]. In 1999, a Greek study con-
ducted to determine the increased spread of VRE coloniza-
tion reported a prevalence of VRE colonization of 1.2%. In
2003, however, the corresponding figure was 34.9% [2].
Increase of VRE poses several challenges, including firstly
the sole availability of expensive new antimicrobials for
therapy of infections due to VRE, since most VRE are also
resistance to multiple other economically acceptable
drugs in developing countries, e.g., aminoglycosides or
ampicilin, and secondly the possibility that the vancomy-
cin resistance genes present in VRE may be transferred to
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other gram-positive microorganisms such as Staphylococ-
cus aureus [3].
Patients with chronic renal failure undergoing hemodial-
ysis are at increased risk for acquiring VRE [1]. In an U.S.
study, 17.8% of hemodyalysis patients became colonized
with VRE, an incidence rate of one case per 9.8 patient-
years of follow-up [4].
In the so far only existing – but unpublished – Iranian
study, the risk of VRE colonization in hemodialysis
patients was 3.78 times higher than that of all other
patients [5]. Previous studies showed significant associa-
tion between VRE colonization in hemodialysis patients
and several factors including non-ambulatory status [6,7],
hospitalization [6,8,9], intensive care unite (ICU) stays
[8], receipt of antibiotic [6] use of vancomycin [4,6-8,10],
age [11], type of dialysis [9], anemia [9], and leukocytosis
[9]. Yet, because the reasons for the higher prevalence in
hemodialysis patients are not fully clear and because there
is only limited data for Iran, we decided to study risk fac-
tors for VRE colonization in these patients.
Methods
This cross-sectional prevalence study was conducted in
the two referral dialysis center of Shiraz. (Namazee and
Faghihi Hospital). Shiraz is the largest city in the southern
part of Iran. The university hospitals in Shiraz serve as
referral centers for one-quarter of the Iran's medical cases
with about 21,000 admissions per year. Rectal swabs were
obtained from all consenting hemodialysis patients (n =
146) of these dialysis centers during March 2005. Acute
hemodialysis patients were excluded from this cross-sec-
tional study. These swabs were immediately transported
to the microbiology laboratory using cephalexin-aztre-
nam-arabinose agar transport medium.
Culture media and condition
Cephalexin-aztreonam-arabinose agar (CAA) was pre-
pared by adding 40 g of Columbia agar base (Unipath,
Basingstoke, United Kingdom), 10 g of arabinose (Sigma
Chemical Co., Poole, United Kingdom), and 3.6 mL of
phenol red (2%; BDH, Lutterworth, United Kingdom) to
1 liter of de-ionized water. The medium was mixed, and
the pH was adjusted to 7.8. The agar was autoclaved at
114°C for 20 minutes. Fresh sterile solutions of aztre-
onam (Bristol-Myers Squibb, Hounslow, United King-
dom) and cephalexin (Sigma) were added to give final
concentrations of 75 and 50 mg/liter, respectively [12].
Swabs were streaked on the surface of CAA agar. The plates
were incubated at 37°C in air for 24 h and examined for
growth and fermentation of arabinose. A change in the
color of the medium surrounding the colony, from red to
yellow, indicated arabinose fermentation.
Conventional organism identification and susceptibility 
testing
Red to yellow colonies resembling enterococci on the
CCA plates were further identified by conventional labo-
ratory methods, including Gram staining and determina-
tion of colonial morphology and biochemical and growth
characteristics [13]. Isolates that were likely VRE were
screened for vancomycin resistance by using brain heart
infusion agar (BHIA) containing 6 mg of vancomycin per
liter and BHIA containing 16 mg of vancomycin per liter.
The vancomycin susceptibility of each isolate was con-
firmed by disk susceptibility testing by National Commit-
tee for Clinical Laboratory Standards (NCCLS) methods
[14]. The MICs of vancomycin and teicoplanin for the iso-
lates were further determined by the Etest (AB Biodisk).
Molecular typing
Molecular typing of VRE strains was performed using ran-
dom-amplified polymorphic DNA (RAPD) according to
the method described by Barbier et al. earlier [15]. Primer
P15 was used. PCR products were run on 1.5% agarose
gels and stained with ethidium bromide.
Data acquisition and statistical analysis
Study personnel used standardized forms to abstract data
from the patient's medical records. A baseline form was
completed on all patients, which contained data on
demographic information, cause of end-stage renal dis-
ease, duration of renal replacement therapy, frequency of
dialysis, antibiotic consumption during previous 2
month, hospitalization during previous year, mobility
status and albumin level. We selected these items for eval-
uation about risk factors of VRE colonization after a
review of items was used in similar studies. The data were
entered into and analyzed with SPSS version 11.5. Stand-
ard descriptive statistical techniques were used to deter-
mine prevalence of VRE colonization among
hemodialysis patients. For determining risk factors for
VRE colonization, the VRE positive and negative groups
were compared using Man-Whitney U test for continuous
and the Fisher exact test for categorical data. For all analy-
ses, a type 1 error of 0.05 was applied.
The study was approved by the local ethics committee.
Ethical considerations including privacy of personal data
were regarded during all of the steps of the research. The
questionnaires did not include any personal identifica-
tion.
Results
A total of 146 patients (79 male) with a median age of 50
(range: 18–81) years were screened for VRE. The median
duration of dialysis treatment was 18 months (range: 1 –
168). Most patients had diabetes mellitus (29.5%) and
hypertension (43.8%) as an underlying disease, and
23.3% of them had limited motility function. Only 1.4%
of the studied patients had received antibiotic during the
previous 2 months, and 6.8% hospitalized during the pre-
vious year. (Table 1)
Among these patients, 9 (6.2%) were colonized with VRE.
All VRE strains were genotypically distinguishable (Figure
1). None of the patients presented with infection. VariousBMC Infectious Diseases 2007, 7:52 http://www.biomedcentral.com/1471-2334/7/52
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factors were analyzed as possible predictors of VRE colo-
nization including: age, sex, underlying kidney disease,
duration of dialysis, frequency of dialysis, serum albumin
concentration and motility status (Table 1). The only sta-
tistically significant differences between VRE-positive and
VRE-negative patients were "antibiotic consumption dur-
ing previous 2 month" (P = 0.003) and "hospitalization
during previous year" (P = 0.0016). Both patients having
received antibiotics within the previous 2 months also
have been hospitalized during the past year.
Discussion
Patients with chronic renal failure who are undergoing
hemodialysis are at increased risk for acquiring VRE.
Hemodialysis-dependent patients are at increased risk for
VRE for several reasons: they have extensive contact with
healthcare system, they are often in close proximity to
other VRE patients, they frequently have multiple co-mor-
bid conditions, and they often receive repeated prolonged
courses of antibiotics including vancomycin [1].
To our knowledge, this study is the first to define the prev-
alence of VRE colonization in a cohort of long-term out-
patient dialysis patients in Iran. We found VRE rectal
carriage in 6.2% of hemodialysis patients, a result similar
to those reported in a number of previous studies that
have examined VRE colonization among dialysis patients.
VRE prevalence was 9.5% at the center affiliated with the
university of Maryland hospital [16], 9% among 111 dial-
ysis patients near New York City [10], 6% at the Vander-
bilt University Medical Center [7], and 8.1% at Johns
Hopkins University Hospital [4].
An increased risk of VRE infection and colonization has
been associated with non-ambulatory status [6,7], receipt
of antibiotic [6], hospitalization [6,8,9], ICU stays [8], use
of vancomycin [4,6-8,10], anemia [9], and leukocytosis
[9]. However, our study found only association between
hospitalization and antibiotic consumption with VRE col-
onization. Interestingly, both patients having received
antibiotics within the previous 2 months also have been
hospitalized during the past year. The factor 'hospitaliza-
tion during the past year' might well be a surrogate for
antibiotic consumption. It can be speculated that the
small number of VRE isolate limited our ability to evalu-
ate risk factors. Furthermore, the yield of rectal swabs
when compared to fresh stool samples has been demon-
RAPD-PCR typing of 9 VRE isolates including 1 not related  control strain (lane 11) Figure 1
RAPD-PCR typing of 9 VRE isolates including 1 not related 
control strain (lane 11). Legend: Lane 1 and 12: 100 bp 
lambda ladder; lanes 2 – 10: VRE strains isolated from 
chronic dialysis patients in Shiraz, Iran; lane 11: not related 
VRE strain isolated at the Vienna General Hospital in March 
2007.
Table 1: Based-line characteristics and comparison of hemodialysis patients cultured versus not cultured for VRE colonization- Shiraz; 
2005
Total VRE No VRE P value
- Patients 146 9 137 -
- age (years), median (range) 50 (18–81) 50 (18 – 81) 57 (24 – 72) 0.389
- Gender, male: female 67:79 5:4 74:63 1.000
- Underlying kidney disease 1.000
- Diabetes mellitus 43 (29.5%) 3 (33.3%) 40 (29.2%)
- Hypertension 64 (43.8%) 4 (44.4%) 60 (43.8%)
- Others 39 (26.7%) 2 (22.2%) 37 (27%)
- Duration of dialysis (months), median (range) 18 (1–168) 18 (1 – 168) 15.5 (6 – 64) 0.758
- Frequency of dialysis, median (range) per month 12 (4–12) 12 (4 – 12) 8 (8 – 12) 0.486
- Serum albumin concentration (mg(dl), median (range) 4.2 (2.6–5.4) 4.2 (2.6 – 5.4) 4.3 (3.5 – 5) 0.572
- Motility status 0.213
- Normal 112 (76.7%) 5 (55.6%) 107 (78.1%)
- Limited 34 (23.3%) 4 (44.4%) 30 (21.9%)
- Antibiotic consumption during previous 2 month 2 (1.4%) 2 (22.2%) 0 (0%) 0.003
- Hospitalization during previous year 10 (6.8%) 3 (33.3%) 7 (5.1%) 0.016BMC Infectious Diseases 2007, 7:52 http://www.biomedcentral.com/1471-2334/7/52
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strated not to be high [17], and the use of broth enrich-
ment might have increased the yield in VRE. Novicki et al.
demonstrated in 2004 [18] that addition of a broth
enrichment step leads to the detection of significantly
more VRE isolates than direct plating alone. Therefore, the
used sampling technique might be a second potential lim-
itation of our study with regards to underestimating the
true prevalence as well as potential misclassification of
controls.
Yet, Reisner et al. [19] clearly showed that use of an
enrichment broth medium is required to recover VRE con-
taminating environmental surfaces; however, direct inoc-
ulation to selective solid medium is adequate to recover
VRE in patient perianal specimens. The purpose of our
study, however, was not to determine a precise estimation
of the prevalence in hemodialysis patients, but to obtain
enough information to calculate risk factors for VRE car-
riage. Furthermore, in an epidemiological sense pertain-
ing to the risk of transmission it remains debatable how
relevant a VRE carrier is, if the isolate is only detectable by
means of enrichment cultures.
Because there is no commonly agreed regimen to eradi-
cate VRE colonization, efforts to preventing VRE's spread
are paramount [8]. Current experience emphasizes con-
tinued enforcement of infection-control measures and
prudent use of antibiotics. These interventions may have
a beneficial impact on the rapidly rising rates of VRE
among chronic hemodialysis patients. However, improv-
ing compliance with infection control measures and pru-
dent use of antibiotics will be challenging, since generally,
compliance is low.
Conclusion
VRE colonization is an under-recognized problem among
chronic dialysis patients in Iran. VRE colonization is asso-
ciated with antibiotic consumption and hospitalization.
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